Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Preclinical and clinical results with Virulizin in pancreatic cancer presented at AACR meeting

April 12, 1999

LeukoSite and Ilex hold pre-BLA meeting with FDA

April 12, 1999

GVAX prostate cancer vaccine enters additional phase I/II trial

April 9, 1999

NeoPharm to collaborate with NCI on cytotoxic cancer ligand

April 9, 1999

Progress with AltaRex's AIT products for cancer

April 8, 1999

M-Vax cancer vaccine granted orphan drug designation

April 6, 1999

Antisoma's Theragyn granted orphan drug status in the U.S.

April 6, 1999

DSMB completes interim evaluation of Maxamine phase III clinical trials

April 1, 1999

Reanalysis of data attributes greater efficacy to Multikine

March 30, 1999

Procyon receives Canadian patent for PSP94

March 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...